GlobeNewsWire
06 Oct 2025, 23:00 UTC · 49w ago
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition
Verdict
Headline takes no side. We score QLGN +0.40 — moderately bullish.
- Expected · QLGN
+0.40moderately bullish
−1 bearish0bullish +1More positive than 64% of ticker scores this week
- Actual





